Optimizing Antituberculosis Therapy in Adults With Tuberculous Meningitis
Optimizing Antituberculosis Therapy in Adults With Tuberculous Meningitis Based on N-Acetyltransferase Type 2 Genotyping
Sponsor: Beijing Chest Hospital
Listed as NCT03787940, this NA trial focuses on Tuberculous Meningitis and remains ongoing. Sponsored by Beijing Chest Hospital, it has been updated 7 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Feb 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Mar 2021 — Feb 2023 [monthly]
Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Aug 2019 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jan 2019 — Aug 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Beijing Chest Hospital
For direct contact, visit the study record on ClinicalTrials.gov .